Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way anti-cancer immunotherapy is administered from intravenous administration to ...
Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer immunotherapy is administered from intravenous ...
A Prescription Drug User Fee Act target date of May 24, 2026 has been set for the application. Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results